REG - BWP REIT PLC - ADMISSION AND FIRST DAY OF DEALINGS ON IPSX

ComcastAnnouncement

16/11/2022 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221116:nRSP6111Ga&default-theme=true

RNS Number : 6111G  BWP REIT PLC  16 November 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, OR IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH
AFRICA OR ANY OTHER JURISDICTION WHERE SO TO DO WOULD OR MIGHT CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS FOR THE PURPOSES OF
THE UK VERSION OF REGULATION (EU) 2017/1129, WHICH FORMS PART OF UK DOMESTIC
LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 OR AN ADMISSION
DOCUMENT AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE OR
SUBSCRIPTION IN ANY JURISDICTION, INCLUDING (WITHOUT LIMITATION) THE UNITED
STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA. INVESTORS SHOULD NOT SUBSCRIBE
FOR, OR OTHERWISE PURCHASE, ACQUIRE, SELL OR DISPOSE OF, ANY OF THE SECURITIES
REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF THE INFORMATION
CONTAINED IN THE ADMISSION DOCUMENT PUBLISHED BY THE COMPANY.

BWP REIT PLC

ADMISSION AND FIRST DAY OF DEALINGS ON IPSX WHOLESALE FOLLOWING £35 MILLION
CAPITAL RAISE

LANDMARK LEEDS OFFICE BECOMES THIRD COMPANY TO HAVE SHARES ADMITTED TO TRADING
ON IPSX

16 November 2022

 

BWP REIT PLC ("BWP REIT" or the "Company"), a newly formed single asset
company established to acquire Bridgewater Place ("Bridgewater Place" or the
"Property"), an office-led mixed use property situated in a prime location in
central Leeds, is pleased to announce that its ordinary shares with a nominal
value of 10 pence each ("Ordinary Shares") have today been admitted to trading
on the Wholesale segment of the International Property Securities Exchange
("IPSX") ("Admission").  Dealings in the Ordinary Shares will commence at
9.00 am today. In total, 35,050,000 Ordinary Shares have been admitted to
trading on the Wholesale segment of IPSX.

Completion of the acquisition of the Property has also taken place
automatically on Admission.

 

The Ordinary Shares will trade under the ticker 'BWP'. The ISIN number of the
Ordinary Shares is GB00BQ1NFW69 and the SEDOL code is BQ1NFW6.

 

WH Ireland Limited ("WH Ireland") acted as IPSX Lead Adviser and Settlement
Agent.

 

BWP REIT becomes the third company to be admitted to trading on IPSX. The
platform is a FCA Regulated Investment Exchange and the world's first such
exchange dedicated to single asset real estate companies and those owning
multiple assets with commonality. IPSX Wholesale is reserved for institutional
and qualified professional investors, while the IPSX Prime segment of the
market is open to all investors and aims to give retail investors the ability
to acquire tradable shares in institutional quality real estate assets.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

 M7 Real Estate Financial Services Ltd (AIFM)                                             (via FTI Consulting below)
 Richard Croft, David Ebbrell, Tony Edgley

 WH Ireland Limited (IPSX Lead Adviser and Settlement Agent)                              T: (http://www.m7mlreit.co.uk) 020 7220 1666
 Advisory - Chris Hardie, Darshan Patel, Sarah Mather,
                                         Andrew
 de Andrade

 FTI Consulting (PR Adviser)                                                              Tel: 020 3727 1000
 Richard Sunderland, Eve Kirmatzis, Oliver Parsons                                        E: M7@FTIConsulting.com

Further information on the Company can be found on its website
www.bwpreit.com.

 

Important notice

 

The content of this announcement, which has been prepared by and is the sole
responsibility of the Company, has been approved by M7 Real Estate Financial
Services Ltd (which is authorised and regulated by the Financial Conduct
Authority) solely for the purposes of section 21(2)(b) of the Financial
Services and Markets Act 2000, as amended.

 

This announcement is being issued in the United Kingdom to and/or is directed
only at persons who are professional clients or eligible counterparties for
the purposes of the FCA's Conduct of Business Sourcebook. The opportunity to
invest in the Company is only available to such persons in the United Kingdom
and this announcement must not be relied or acted upon by any other persons in
the United Kingdom.

 

This announcement does not constitute an offer or recommendation concerning
the Ordinary Shares. Any prospective investor must carry out their own due
diligence and should form their own assessment, and is recommended to consult
an independent professional adviser as to the suitability of the Ordinary
Shares and evaluate all matters addressed herein.

 

The information contained in this announcement is for background purposes only
and does not purport to be full or complete. No reliance may be placed for any
purpose on the information contained in this announcement or its accuracy,
fairness or completeness.

 

The distribution of this annoucement and/or any offer, sale or purchase of, or
application to subscribe for, the Ordinary Shares may in certain jurisdictions
be restricted by law. Prospective investors and persons into whose posession
any document or other information referred to herein are required to inform
themselves about, and observe, any such restrictions. It is the responsibility
of each prospective investor to satisfy itself as to full compliance with the
applicable laws and regulations of any relevant jurisdiction, including
obtaining any requisite governmental, regulatory or other consent and
observing any other formality presented in such jurisdiction. Neither this
announcement nor the information contained herein is for publication,
distribution or release, in whole or in part, directly or indirectly, in or
into, the United States (including its territories and possessions, any State
of the United States and the District of Columbia), Australia, Canada, Japan,
South Africa or any other jurisdiction where to do so would constitute a
violation of the relevant laws of such jurisdiction.

 

This announcement does not constitute or form a part of any offer or
solicitation to purchase or subscribe for securities in the United States,
Australia, Canada, Japan, South Africa or any other jurisdiction where such
offer or sale would be unlawful. The Ordinary Shares mentioned herein have not
been, and will not be, registered under the United States Securities Act of
1933, as amended (the "Securities Act"), or with any securities regulatory
authority of any state or other jurisdiction in the United States. The
Ordinary Shares may not be offered or sold in the United States except
pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act. No public offering of
securities is being or will be made in the United States.

 

This announcement includes statements that are, or may be deemed to be,
"forward-looking statements". These forward-looking statements may be
identified by the use of forward-looking terminology, including the terms
"believes", "estimates", "plans", "projects", "anticipates", "expects",
"intends", "may", "will" or "should" or, in each case, their negative or other
variations or comparable terminology, or by discussions of strategy, plans,
objectives, goals, future events or intentions. These statements reflect
beliefs of the Directors (including based on their expectations arising from
pursuit of the Company's strategy) as well as assumptions made by the
Directors and information currently available to the Group. Although the
Directors consider that these beliefs and assumptions are reasonable, by their
nature, forward-looking statements involve known and unknown risks,
uncertainties, assumptions and other factors that may cause the Group's actual
financial condition, results of operations, cash flows, liquidity or prospects
to be materially different from any future such metric expressed or implied by
such statements. Past performance cannot be relied upon as a guide to future
performance and should not be taken as a representation that trends or
activities underlying past performance will continue in the future.
Forward-looking statements speak only as of the date they are made. No
representation is made or will be made that any forward-looking statements
will come to pass or prove to be correct.

 

WH Ireland, which is authorised and regulated in the United Kingdom by the
FCA, is acting exclusively as Lead Adviser for the Company and no-one else in
connection with the Issue and Admission and will not regard any other persons
as its client in relation to the Issue and Admission and will not be
responsible to anyone other than the Company for providing the protections
afforded to clients of WH Ireland, nor for providing advice in connection with
the Issue and Admission or any other matter or arrangement referred to in this
announcement.

 

No key information document has been prepared in respect of this annnouncement
or the Ordinary Shares in accordance with Regulation (EU) No 1286/2014 on key
information documents for packaged retail and insurance-based investment
products (PRIIPs) (and in the case of the United Kingdom, such regulation as
it forms part of UK domestic law by virtue of the European Union (Withdrawal)
Act 2018). Accordingly, the Ordinary Shares are not available to, and no
person may advise on, offer or sell Ordinary Shares for, or to, any retail
client (as defined in MiFID II) in the European Economic Area or the United
Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IPXVQLBFLFLZFBV